期刊文献+

8-O-乙酰哈巴苷防治EB病毒感染的体内外药效学研究 被引量:1

In Vivo and In Vitro Pharmacodynamics Study of 8-O-Acetylharpagide in the Prevention and Treatment of EB Viral Infection
暂未订购
导出
摘要 目的通过体内外试验对8-O-乙酰哈巴苷防治Epstein-Barr病毒(EBV)感染的药效作用进行评价。方法采用实时荧光定量PCR(Real-time RT-PCR)技术观察8-O-乙酰哈巴苷对B95-8细胞内EBV衣壳抗原(VCA)的抑制作用;采用腹腔注射醋酸(HAc)所致小鼠腹腔毛细血管通透性增高模型检测8-O-乙酰哈巴苷对炎症早期的毛细血管通透性亢进和渗出的抑制作用。结果 8-O-乙酰哈巴苷大、中、小剂量组对B95-8细胞内EBV衣壳抗原均具有明显的抑制作用(P<0.01);8-O-乙酰哈巴苷大、中两个剂量组显著抑制醋酸引起的小鼠腹腔毛细血管通透性增高(P<0.01)。结论 8-O-乙酰哈巴苷对EBV感染具有明显的抑制作用。其不仅对EBV衣壳抗原具有明显的抑制作用,并且可以减轻炎症早期的毛细血管通透性亢进和渗出现象。 Objective To assess the pharmacodynamic effects of 8-O-acetylharpagide in the preven- tion and treatment of Epstein - Barr virus (EBV) by in vivo and in vitro trial. Methods The real - time fluo- rescent quantitative PCR ( Real - time RT - PCR) technology was used to observe the inhibition of 8-O-acetyl- harpagide on EBV viral capsid antigen(VCA) in B95 -8 cell. By the intraperitoneal injection of acetic acid, the model of the increased celiac capillary permeability was prepared in mice for the detection of the inhibi- tion of 8-O-acetylharpagide on the hyperfunction and effusion of capillary permeability at the early inflamma- tion. Results In the high - dose, middle - dose and low - dose groups, 8-O-acetylharpagide presented obvi- ous inhibition on EBV - VCA in B95 - 8 separately ( P 〈 0.01 ). In the high - dose and middle - dose groups, 8-O-acetylharpagide inhibited significantly the increased celiac capillary permeability in the mice in- duced by acetic acid( P 〈 O. 01 ). Conclusion 8-O-acetylharpagide presents the obvious inhibition on EBV infection. It not only apparently inhibits EBV - VCA, but also alleviates the hyperfunction and effusion of cap- illary permeability at the early inflammation.
出处 《世界中西医结合杂志》 2013年第4期351-354,共4页 World Journal of Integrated Traditional and Western Medicine
基金 重点学科联合课题(2011ZDXK-03)
关键词 8-O-乙酰哈巴苷 EBV 衣壳抗原 实时聚合酶链反应 8-0-Acetylharpagide EBV Viral Capsid Antigen ( VCA ) Real - Time PolymeraseChain Reaction
  • 相关文献

参考文献20

  • 1Hoshikawa Y, Satoh Y, Murakami M, et al. Evidence of lytic infection of Epstein - Barr virus ( EBV ) in EBV - positive gastric carcinoma [ J ]. Journal of medical virology,2002,66 ( 3 ) : 351 - 359.
  • 2Young LS,Rickinson AB. Epstein - Barr virus:40 years on[ J]. Na- ture reviews Cancer,2004,4 ( 10 ) :757 - 768.
  • 3Bollard CM, Cooper LJ, Heslop HE. Immunotherapy targeting EBV - expressing lymphoproliferative diseases [ J ]. Best Pract Res Clin Hamato1,2008,21 ( 3 ) :405 - 420.
  • 4Ballout M, Germi R, Fafi -kremer S, et al. Real -time quantitative PCR for assessment of antiviral drug effects against Epstein - Barr vi- rus replication and EBV late mRNA expression [ J]. Journal of viro-logical methods ,2007,143 ( 1 ) :38 - 34.
  • 5He Y, Cai S, Zhang G, et al. Interfering with cellular signaling path- ways enhances sensitization to combined sodium butyrate and GCV treatment in EBV - positive tumor cells [ J ]. Virus Res, 2008,135 (1) :175 -180.
  • 6Kawa K. Epstein - Barr virus - - associated diseases in humans [ J ]. International iournal of hematology, 2000,71 ( 2 ) : 108 - 117.
  • 7谢浙裕,秦明珠,房玉玲.8-乙酰基哈帕苷的药理作用[J].国外医药(植物药分册),2005,20(2):56-58. 被引量:10
  • 8周建军,乐秀芳,韩家娴,杨蔚怡.评价抗癌物质活性的改良MTT方法[J].中国医药工业杂志,1993,24(10):455-457. 被引量:108
  • 9吕岫华,刘伟,郝冬梅,刘巧丽,绳秀君,李泽琳,曾毅.中药多糖对EB病毒早期抗原激活的抑制作用[J].北京工业大学学报,2010,36(1):92-97. 被引量:10
  • 10Wang WH, Chang LK, Liu ST. Molecular interactions of Epstein - Barr virus capsid proteins[ J]. J Virol,2011,85 (4) :1615 - 1624.

二级参考文献87

共引文献155

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部